← Open Payments lookup

KATE TAYLOR: Open Payments

NPI 1700024932 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,245 in 20 payments from 15 companies in 2025. Trend: 2023 $537 · 2024 $904 · 2025 $1,245

Food & beverage: $1,245
CompanyPaymentsAmount
Eisai Inc.2$149
Hologic Sales and Service, LLC2$134
Otsuka Pharmaceutical Development & Commercialization, Inc.1$125
Takeda Pharmaceuticals U.S.A., Inc.1$121
Lilly USA, LLC1$119
SANOFI-AVENTIS U.S. LLC1$119
GlaxoSmithKline, LLC.1$118
Novo Nordisk Inc1$112
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$91
ABBVIE INC.3$55

Products named: LEQEMBI, REXULTI, APTIMA, GATTEX, MOUNJARO, TZIELD, AREXVY, XIFAXAN.

Industry payments across TX — which companies pay providers there.